Bio-Rad Laboratories, Inc. (BIO)

USD 323.94

(-4.12%)

Total Debt Summary of Bio-Rad Laboratories, Inc.

  • Bio-Rad Laboratories, Inc.'s latest annual total debt in 2023 was 1.4 Billion USD , up 17.34% from previous year.
  • Bio-Rad Laboratories, Inc.'s latest quarterly total debt in 2024 Q3 was 1.2 Billion USD , down -0.33% from previous quarter.
  • Bio-Rad Laboratories, Inc. reported annual total debt of 1.19 Billion USD in 2022, up 10789.58% from previous year.
  • Bio-Rad Laboratories, Inc. reported annual total debt of 11 Million USD in 2021, down -21.72% from previous year.
  • Bio-Rad Laboratories, Inc. reported quarterly total debt of 1.2 Billion USD for 2024 Q3, down -0.33% from previous quarter.
  • Bio-Rad Laboratories, Inc. reported quarterly total debt of 1.39 Billion USD for 2024 Q1, down -0.44% from previous quarter.

Annual Total Debt Chart of Bio-Rad Laboratories, Inc. (2023 - 1989)

Historical Annual Total Debt of Bio-Rad Laboratories, Inc. (2023 - 1989)

Year Total Debt Total Debt Growth
2023 1.4 Billion USD 17.34%
2022 1.19 Billion USD 10789.58%
2021 11 Million USD -21.72%
2020 14.05 Million USD -96.8%
2019 439.75 Million USD 0.07%
2018 439.43 Million USD 1.02%
2017 435 Million USD 0.11%
2016 434.52 Million USD -0.34%
2015 436 Million USD 0.01%
2014 435.97 Million USD -0.33%
2013 437.4 Million USD -40.42%
2012 734.16 Million USD 0.23%
2011 732.51 Million USD -24.04%
2010 964.28 Million USD 29.77%
2009 743.05 Million USD 63.11%
2008 455.55 Million USD -0.41%
2007 457.43 Million USD 6.71%
2006 428.66 Million USD -0.08%
2005 429.02 Million USD -1.47%
2004 435.43 Million USD 84.31%
2003 236.25 Million USD 108.61%
2002 113.25 Million USD -42.9%
2001 198.35 Million USD -10.45%
2000 221.5 Million USD -15.2%
1999 261.2 Million USD 405.22%
1998 51.7 Million USD 3.82%
1997 49.8 Million USD 304.88%
1996 12.3 Million USD -65.06%
1995 35.2 Million USD -26.51%
1994 47.9 Million USD -39.06%
1993 78.6 Million USD -16.65%
1992 94.3 Million USD -2.38%
1991 96.6 Million USD 36.25%
1990 70.9 Million USD 17.19%
1989 60.5 Million USD 13.94%

Peer Total Debt Comparison of Bio-Rad Laboratories, Inc.

Name Total Debt Total Debt Difference
Abbott Laboratories 15.87 Billion USD 91.143%
Allurion Technologies Inc. 41.85 Million USD -3258.805%
Artivion, Inc. 359.34 Million USD -291.243%
Avanos Medical, Inc. 209.1 Million USD -572.355%
Butterfly Network, Inc. 25.02 Million USD -5517.513%
Butterfly Network, Inc. 25.02 Million USD -5517.513%
Boston Scientific Corporation 9.49 Billion USD 85.189%
Perspective Therapeutics, Inc. - USD -Infinity%
CONMED Corporation 991.25 Million USD -41.83%
Edwards Lifesciences Corporation 694.9 Million USD -102.316%
Paragon 28, Inc. 112.03 Million USD -1154.927%
Glaukos Corporation 383.73 Million USD -266.368%
Globus Medical, Inc. 520.4 Million USD -170.155%
Inspire Medical Systems, Inc. 24.84 Million USD -5558.436%
Integer Holdings Corporation 1.04 Billion USD -35.058%
Medtronic plc 26.04 Billion USD 94.602%
Nevro Corp. 221.82 Million USD -533.78%
Owlet, Inc. 15.21 Million USD -9139.583%
Penumbra, Inc. 234.34 Million USD -499.93%
Vicarious Surgical Inc. 14.83 Million USD -9378.796%
Smith & Nephew plc 3.08 Billion USD 54.413%
Sonendo, Inc. 40.35 Million USD -3384.164%
STERIS plc 3.38 Billion USD 58.444%
Stryker Corporation 12.99 Billion USD 89.181%
Vapotherm, Inc. 112.39 Million USD -1150.885%
Zimmer Biomet Holdings, Inc. 5.99 Billion USD 76.55%